flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 in Patients with Obesity-Related Heart Failure and Type 2 Diabetes FLOW trial Ozempic® (semaglutide injection)
Description
It does not confirm location eligibility, clinical approval, product availability, financing approval, or total cost
You can respond with something like, Everything was delicious, Im just comfortably full now. Or, Im pacing myself, I might grab more later. You dont owe anyone an explanation that youre on a weight loss medication if youre not comfortable sharing that
Gastrointestinal side effects, while common, rarely lead to treatment discontinuation
Off-label prescribing is common, legal, and standard medical practice across many areas of medicine
They could include worrying that youre eating too much, shaming yourself for what you just ate, or constantly planning your next meal, perhaps even while eating your current one
Thats my three-course, she told British Vogue
